Today: 9 June 2026
Bloom Energy stock whipsaws, ends higher as traders stick with data-center power bet

Bloom Energy stock whipsaws, ends higher as traders stick with data-center power bet

New York, Jan 12, 2026, 19:21 EST — After-hours

  • Bloom Energy shares ended the day up 2.1% but dipped 0.1% in after-hours trading following a sharp intraday swing.
  • Traders remain fixated on a utility-scale fuel-cell project linked to American Electric Power’s Wyoming initiative.
  • Next up: details on the unnamed offtake customer and when Bloom will release its next earnings report.

Shares of Bloom Energy Corp (BE) climbed 2.1% to $136.87 during Monday’s regular session, after fluctuating between $128.45 and $138.17. In after-hours trading, the stock slipped 0.1% to $136.72. About 12.3 million shares changed hands on the day.

The latest shift is significant since Bloom now stands in for a broader wager: the pace at which the U.S. power grid can supply new data centers without multi-year upgrades. Investors have rushed to back anything resembling “firm” power — electricity available on demand, not just when the wind blows or the sun shines.

Bloom sells solid oxide fuel cells, devices that produce electricity via an electrochemical process instead of combustion. Supporters say the product is timely: data centers demand speed, reliability, and on-site solutions, even though natural gas often remains the primary fuel source.

American Electric Power set the stage earlier this month when it revealed in an SEC filing that an unregulated subsidiary signed an unconditional purchase agreement for a large chunk of its option on solid oxide fuel cells. The deal, worth roughly $2.65 billion, is linked to a planned generation project near Cheyenne, Wyoming.

The filing also revealed that AEP secured a 20-year offtake agreement — a deal to purchase the plant’s entire output — with a “high investment grade” third-party customer. AEP expects to meet the conditions tied to this contract by the second quarter of 2026. If those conditions aren’t fulfilled, AEP will receive compensation for capital and costs. SEC

Fuel-cell stocks showed a mixed picture. Plug Power edged up roughly 3.9%, while FuelCell Energy dipped around 0.4%. Ballard Power added about 1.1%. GE Vernova, the power equipment maker, rose close to 2.8%.

Bloom’s upside is clear: larger utility-scale orders combined with growth in data-center clients might elevate a niche product to mainstream status. Still, the stock already reflects high execution expectations, and the journey so far has been anything but smooth.

The biggest risk lies in slipping timelines and conditions on major projects, particularly when a facility relies on end-customers, permitting, and construction sequencing. Even a slight delay, cost surge, or constraints on Bloom’s ability to build and deliver units could send the shares tumbling as fast as they climbed.

Heading into Tuesday, traders are keen to see if any fresh details link the Wyoming project to a defined end-customer, and which milestones lie between now and the Q2 2026 condition window. They’ll also be watching to see if the stock’s heavy volume starts to ease up or shifts into profit-taking territory.

Bloom’s events calendar doesn’t show an upcoming earnings date yet. Nasdaq and Zacks put Feb. 26 as the estimated next report date, which, if it holds, would probably be the next big catalyst.

Stock Market Today

  • Plug Power Stock Drops to $3 Amid Cash and Dilution Concerns Ahead of Shareholder Meeting
    June 9, 2026, 9:35 AM EDT. Plug Power (PLUG) shares held near $3.19 before the U.S. open on June 9, down 22% from June 2, as investor concerns about cash liquidity and share dilution re-emerge. The stock slid amid premarket trading while broader markets gained, highlighting investor focus on the company's funding strategy. A Form 144 filing indicated a planned sale of 50,000 shares, adding pressure. Plug Power will webcast its shareholder meeting on June 11, where CEO Jose Luis Crespo will present updates. Recent financials showed a 22% revenue increase to $163.5 million in Q1 but a GAAP net loss of 18 cents per share. The company aims to raise $39.2 million through tax credit sales and plans $275 million from asset monetizations. Concerns remain over dilution as funding needs persist.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA
Previous Story

Tesla stock edges up after hours as robotaxi deadlines, CPI and earnings line up as next tests for TSLA

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread
Next Story

Locked out of $22B: Canadian real estate funds freeze withdrawals as gates spread

Go toTop